Proportion of long-term event-free survivors and lifetime of adult patients not cured after a standard acute lymphoblastic leukemia therapeutic program: adult acute lymphoblastic leukemia-94 trial.
Le, Quoc-Hung
Proportion of long-term event-free survivors and lifetime of adult patients not cured after a standard acute lymphoblastic leukemia therapeutic program: adult acute lymphoblastic leukemia-94 trial. [electronic resource] - Cancer May 2007 - 2058-67 p. digital
Publication Type: Journal Article; Multicenter Study
0008-543X
10.1002/cncr.22632 doi
Adolescent
Adult
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Disease-Free Survival
Female
Follow-Up Studies
Genes, abl--genetics
Humans
Karyotyping
L-Lactate Dehydrogenase--blood
Leukocyte Count
Male
Middle Aged
Myeloid-Lymphoid Leukemia Protein--genetics
Odds Ratio
Oncogene Proteins, Fusion--genetics
Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy
Prognosis
Risk Factors
Survival Rate
Treatment Failure
Proportion of long-term event-free survivors and lifetime of adult patients not cured after a standard acute lymphoblastic leukemia therapeutic program: adult acute lymphoblastic leukemia-94 trial. [electronic resource] - Cancer May 2007 - 2058-67 p. digital
Publication Type: Journal Article; Multicenter Study
0008-543X
10.1002/cncr.22632 doi
Adolescent
Adult
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Disease-Free Survival
Female
Follow-Up Studies
Genes, abl--genetics
Humans
Karyotyping
L-Lactate Dehydrogenase--blood
Leukocyte Count
Male
Middle Aged
Myeloid-Lymphoid Leukemia Protein--genetics
Odds Ratio
Oncogene Proteins, Fusion--genetics
Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy
Prognosis
Risk Factors
Survival Rate
Treatment Failure